Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy

Arch Ophthalmol. 1985 Jul;103(7):912-5. doi: 10.1001/archopht.1985.01050070038026.

Abstract

Thirty-two eyes of 32 patients were treated with 0.5% timolol, 2% pilocarpine, or normal saline five and 30 minutes following neodymium-YAG laser posterior capsulotomy in a randomized, double-masked study. Mean maximum intraocular pressure (IOP) elevation was 8 +/- 2 mm Hg following treatment with normal saline, 5 +/- 3 mm Hg following treatment with 2% pilocarpine, and 1 +/- 2 mm Hg following treatment with 0.5% timolol. Fewer patients treated with 0.5% timolol developed an IOP elevation of 5 mm Hg or more than control patients. On aphakic patient treated with 0.5% timolol developed a maximum IOP greater than or equal to 40 mm Hg. We found that treatment with 0.5% timolol after neodymium-YAG laser posterior capsulotomy provides partial protection from IOP elevation.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Evaluation Studies as Topic
  • Humans
  • Intraocular Pressure / drug effects*
  • Laser Therapy*
  • Lens Capsule, Crystalline / surgery*
  • Lens, Crystalline / surgery*
  • Middle Aged
  • Pilocarpine / therapeutic use*
  • Postoperative Care
  • Timolol / therapeutic use*

Substances

  • Pilocarpine
  • Timolol